Central precocious puberty

Active Ingredient: Triptorelin

Indication for Triptorelin

Population group: only children (1 year - 12 years old)

Treatment of confirmed central precocious puberty (girls under 9 years, boys under 10 years).

For this indication, competent medicine agencies globally authorize below treatments:

1.875-3.75 mg once every 3-4 weeks

Route of admnistration

Subcutaneous

Defined daily dose

1.88 - 3.75 mg

Dosage regimen

From 1.88 To 3.75 mg once every 28 day(s)

Detailed description

Dosing at the beginning of treatment should be based on body weight, one injection of triptorelin should be injected on days 0, 14, and 28. Thereafter one injection every 4 weeks. Should the effect be insufficient, the injections may be given every 3 weeks. Dosing should be based on body weight according to the table.

Body weightDosing
<20 kg1.875 mg (half dose)
20-30 kg2.5 mg (2/3 dose)
>30 kg3.75 mg (full dose)

Dosage considerations

The dosage is injected every 28 days either subcutaneously (e.g. into the skin of the abdomen, the buttock or thigh) or deep intramuscularly. The injection site should be changed each time.

1.875-3.75 mg once every 3-4 weeks

Route of admnistration

Intramuscular

Defined daily dose

1.88 - 3.75 mg

Dosage regimen

From 1.88 To 3.75 mg once every 28 day(s)

Detailed description

Dosing at the beginning of treatment should be based on body weight, one injection of triptorelin should be injected on days 0, 14, and 28. Thereafter one injection every 4 weeks. Should the effect be insufficient, the injections may be given every 3 weeks. Dosing should be based on body weight according to the table.

Body weightDosing
<20 kg1.875 mg (half dose)
20-30 kg2.5 mg (2/3 dose)
>30 kg3.75 mg (full dose)

Dosage considerations

The dosage is injected every 28 days either subcutaneously (e.g. into the skin of the abdomen, the buttock or thigh) or deep intramuscularly. The injection site should be changed each time.

Active ingredient

Triptorelin

Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins.

Read more about Triptorelin

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.